$ESAB

ESAB Corp

No enriched coverage for $ESAB in the last 7 days.

No SEC Form 4 filings for $ESAB in the last 30 days.

Med

ESAB stockholders elect directors and approve proposals at annual meeting By Investing.com

ESAB Corporation stockholders have elected nine directors, ratified Ernst & Young LLP as their independent auditor, and approved executive compensation at their annual meeting. This information comes from a press release and an 8-K filing. The company also recently reported mixed Q1 2026 financial results, with increased revenue but lower-than-expected EPS, and announced a 20% quarterly dividend hike.

ESAB Corp (NYSE: ESAB) CFO receives new stock option and RSU grants

ESAB Corp's EVP and CFO, R. Brent Jones, was granted 14,210 employee stock options and 33,978 restricted stock units (RSUs) on May 7, 2026. The stock options have an exercise price of $102.39 per share and expire on May 6, 2033, while both the options and RSUs will vest in three equal annual installments starting after the first anniversary of the grant date. These equity awards are designed to align his compensation with the company's long-term performance and encourage retention.

Mitsubishi UFJ Trust & Banking Corp Sells 50,626 Shares of ESAB Corporation $ESAB

Mitsubishi UFJ Trust & Banking Corp reduced its stake in ESAB Corporation by 41.3%, selling 50,626 shares and retaining 72,005 shares valued at approximately $8.04 million. This move comes alongside other institutional investor changes and a significant insider sale by CEO Shyam Kambeyanda. Despite analyst price target reductions, ESAB maintains a "Moderate Buy" consensus rating with an average target price well above its current trading price.